Healthcare Industry News: Extracellular Matrix
News Release - May 7, 2009
CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York
New York – May 6, 2009 – (HSMN NewsFeed) - CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique Extracellular Matrix (ECM(TM)) biomaterial devices that harness the body’s innate ability to repair damaged cardiovascular tissue, today announced that Robert G. Matheny, M.D., Chief Scientific Officer, will present an update on the company’s ECM Technology(TM) at the 2009 Advanced Cardiac Techniques in Surgery (ACTS) symposium in New York.The presentation entitled “Applications of Extracellular Matrix (ECM) in Repair of Cardiac Structures” will take place today, Wednesday, May 6th at 12:10 p.m. EDT in the Equitable Center as part of the Video Presentations on New Technologies Session.
“We are pleased to have Dr. Matheny included in this symposium that will explore the most recent advances in the surgical and interventional treatment of cardiovascular disease,” commented Beecher Lewis, President and Chief Operating Officer of CorMatrix Cardiovascular. “The CorMatrix ECM Technology is an exciting advancement in cardiovascular surgery and with more than 10,000 implants we are creating a paradigm shift in pericardial closure and cardiac tissue repair.”
About CorMatrix(R) ECM Technology(TM)
CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM(TM) products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark for its ECM Technology as an implant for pericardial closure, and clearance in the U.S. for use in cardiac tissue repair.
About CorMatrix Cardiovascular, Inc.
CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and delivering innovative cardiovascular devices that harness the body’s own innate ability to remodel damaged tissue. For more information, visit www.cormatrix.com.
Source: CorMatrix Cardiovascular
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
